1202941-04-5 Usage
Uses
Used in Pharmaceutical Synthesis:
3-Bromo-4-hydrazinylpyridine is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Production:
In the agrochemical industry, 3-Bromo-4-hydrazinylpyridine is utilized as a precursor in the production of various agrochemicals, potentially enhancing crop protection and yield.
Used in Heterocyclic Compound Preparation:
3-Bromo-4-hydrazinylpyridine serves as a building block for the preparation of heterocyclic compounds, which are important in various chemical and pharmaceutical applications due to their diverse chemical properties and reactivity.
Used in Drug Discovery and Development:
Owing to its anti-tumor and anti-inflammatory properties, 3-bromo-4-hydrazinylpyridine is used as a potentially valuable ingredient in drug discovery and development, providing a foundation for creating novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 1202941-04-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,2,9,4 and 1 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1202941-04:
(9*1)+(8*2)+(7*0)+(6*2)+(5*9)+(4*4)+(3*1)+(2*0)+(1*4)=105
105 % 10 = 5
So 1202941-04-5 is a valid CAS Registry Number.
1202941-04-5Relevant articles and documents
PYRAZOLE DERIVATIVES AS MALT1 INHIBITORS
-
Paragraph 0783-0785, (2020/01/04)
Disclosed are compounds, compositions and methods for treating of diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT 1. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, R4, R5, and G, are defined herein.
FUSED HETEROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS
-
Paragraph 0448; 0449, (2018/06/26)
The invention is fused heterocyclic compounds of formula (I), and salts thereof, compositions thereof, and methods of use therefor. In particular, disclosed herein are certain fused heterocyclic compounds that can be useful for inhibiting protein kinase, including Bruton’ s tyrosine kinase (Btk), and for treating disorders mediated thereby.
FUSED HETEROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS
-
Paragraph 0446; 0448; 0449, (2014/11/13)
The invention is fused heterocyclic compounds of formula (I), and salts thereof, compositions thereof, and methods of use therefor. In particular, disclosed herein are certain fused heterocyclic compounds that can be useful for inhibiting protein kinase, including Bruton's tyrosine kinase (Btk), and for treating disorders mediated thereby.
